サマリー

上咽頭癌治療の世界市場規模は、2022年の100万米ドルから2029年には100万米ドルになると予測されており、2023年から2029年までのCAGRは%であると予測されています。
上咽頭癌治療薬の米国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルまで増加すると予測されます。
上咽頭癌治療の中国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
上咽頭癌治療のヨーロッパ市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年までに百万米ドルに増加すると推定されます。
世界の主要な上咽頭癌治療のプレーヤーは、ファイザー、サノフィ、メルク、イーライリリー、テバ・ファーマシューティカル・インダストリーズ、フレゼニウス、シクラセル・ファーマシューティカルズ、F・ホフマン-ラ・ロシュ、セルジーンコーポレーションなどをカバーしています。売上高では、世界の2大企業が2022年にほぼ％のシェアを占めています。
LPI（エルピーアイ）の最新リサーチレポート「上咽頭癌治療薬の業界予測」は、過去の売上高から2022年の世界の上咽頭癌治療薬の総売上高を検討し、2023年から2029年の上咽頭癌治療薬の売上予測について地域や市場分野ごとに包括的に分析しています。上咽頭癌治療薬の売上を地域別、市場分野別、サブセクター別に分類し、世界の上咽頭癌治療薬産業の詳細な分析を百万米ドル単位で提供します。
本インサイトレポートでは、世界の上咽頭癌治療産業の状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにします。また、本レポートでは、加速する世界の上咽頭癌治療市場におけるこれらの企業の独自のポジションをより良く理解するために、上咽頭癌治療のポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、主要グローバル企業の戦略を分析しています。
本インサイトレポートでは、上咽頭癌治療の世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、この調査予測は、世界の上咽頭癌治療の現状と将来の軌道について非常にニュアンスのある見方を提供します。
本レポートでは、上咽頭がん治療市場の製品タイプ、用途、主要プレイヤー、主要地域・国別の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
エッセンス
タキソテール
ブレオマイシン（Bleomycin
メトトレキサート
用途別セグメンテーション
病院薬局
小売薬局
オンライン薬局
また、本レポートでは、地域別に市場を分割しています：
米州
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中近東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選定されています。
ファイザー
サノフィ
メルク
イーライリリー
テバ・ファーマシューティカル・インダストリーズ
フレゼニウス
シクラセル・ファーマシューティカルズ
F・ホフマン・ラ・ロシュ
セルジーン株式会社
バイオディエム

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nasopharyngeal Carcinoma Treatment Market Size 2018-2029
2.1.2 Nasopharyngeal Carcinoma Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nasopharyngeal Carcinoma Treatment Segment by Type
2.2.1 Ellence
2.2.2 Taxotere
2.2.3 Bleomycin
2.2.4 Methotrexate
2.3 Nasopharyngeal Carcinoma Treatment Market Size by Type
2.3.1 Nasopharyngeal Carcinoma Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nasopharyngeal Carcinoma Treatment Market Size Market Share by Type (2018-2023)
2.4 Nasopharyngeal Carcinoma Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Nasopharyngeal Carcinoma Treatment Market Size by Application
2.5.1 Nasopharyngeal Carcinoma Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nasopharyngeal Carcinoma Treatment Market Size Market Share by Application (2018-2023)
3 Nasopharyngeal Carcinoma Treatment Market Size by Player
3.1 Nasopharyngeal Carcinoma Treatment Market Size Market Share by Players
3.1.1 Global Nasopharyngeal Carcinoma Treatment Revenue by Players (2018-2023)
3.1.2 Global Nasopharyngeal Carcinoma Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Nasopharyngeal Carcinoma Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nasopharyngeal Carcinoma Treatment by Regions
4.1 Nasopharyngeal Carcinoma Treatment Market Size by Regions (2018-2023)
4.2 Americas Nasopharyngeal Carcinoma Treatment Market Size Growth (2018-2023)
4.3 APAC Nasopharyngeal Carcinoma Treatment Market Size Growth (2018-2023)
4.4 Europe Nasopharyngeal Carcinoma Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size Growth (2018-2023)
5 Americas
5.1 Americas Nasopharyngeal Carcinoma Treatment Market Size by Country (2018-2023)
5.2 Americas Nasopharyngeal Carcinoma Treatment Market Size by Type (2018-2023)
5.3 Americas Nasopharyngeal Carcinoma Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nasopharyngeal Carcinoma Treatment Market Size by Region (2018-2023)
6.2 APAC Nasopharyngeal Carcinoma Treatment Market Size by Type (2018-2023)
6.3 APAC Nasopharyngeal Carcinoma Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nasopharyngeal Carcinoma Treatment by Country (2018-2023)
7.2 Europe Nasopharyngeal Carcinoma Treatment Market Size by Type (2018-2023)
7.3 Europe Nasopharyngeal Carcinoma Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nasopharyngeal Carcinoma Treatment by Region (2018-2023)
8.2 Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nasopharyngeal Carcinoma Treatment Market Forecast
10.1 Global Nasopharyngeal Carcinoma Treatment Forecast by Regions (2024-2029)
10.1.1 Global Nasopharyngeal Carcinoma Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Nasopharyngeal Carcinoma Treatment Forecast
10.1.3 APAC Nasopharyngeal Carcinoma Treatment Forecast
10.1.4 Europe Nasopharyngeal Carcinoma Treatment Forecast
10.1.5 Middle East & Africa Nasopharyngeal Carcinoma Treatment Forecast
10.2 Americas Nasopharyngeal Carcinoma Treatment Forecast by Country (2024-2029)
10.2.1 United States Nasopharyngeal Carcinoma Treatment Market Forecast
10.2.2 Canada Nasopharyngeal Carcinoma Treatment Market Forecast
10.2.3 Mexico Nasopharyngeal Carcinoma Treatment Market Forecast
10.2.4 Brazil Nasopharyngeal Carcinoma Treatment Market Forecast
10.3 APAC Nasopharyngeal Carcinoma Treatment Forecast by Region (2024-2029)
10.3.1 China Nasopharyngeal Carcinoma Treatment Market Forecast
10.3.2 Japan Nasopharyngeal Carcinoma Treatment Market Forecast
10.3.3 Korea Nasopharyngeal Carcinoma Treatment Market Forecast
10.3.4 Southeast Asia Nasopharyngeal Carcinoma Treatment Market Forecast
10.3.5 India Nasopharyngeal Carcinoma Treatment Market Forecast
10.3.6 Australia Nasopharyngeal Carcinoma Treatment Market Forecast
10.4 Europe Nasopharyngeal Carcinoma Treatment Forecast by Country (2024-2029)
10.4.1 Germany Nasopharyngeal Carcinoma Treatment Market Forecast
10.4.2 France Nasopharyngeal Carcinoma Treatment Market Forecast
10.4.3 UK Nasopharyngeal Carcinoma Treatment Market Forecast
10.4.4 Italy Nasopharyngeal Carcinoma Treatment Market Forecast
10.4.5 Russia Nasopharyngeal Carcinoma Treatment Market Forecast
10.5 Middle East & Africa Nasopharyngeal Carcinoma Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Nasopharyngeal Carcinoma Treatment Market Forecast
10.5.2 South Africa Nasopharyngeal Carcinoma Treatment Market Forecast
10.5.3 Israel Nasopharyngeal Carcinoma Treatment Market Forecast
10.5.4 Turkey Nasopharyngeal Carcinoma Treatment Market Forecast
10.5.5 GCC Countries Nasopharyngeal Carcinoma Treatment Market Forecast
10.6 Global Nasopharyngeal Carcinoma Treatment Forecast by Type (2024-2029)
10.7 Global Nasopharyngeal Carcinoma Treatment Forecast by Application (2024-2029)

11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Nasopharyngeal Carcinoma Treatment Product Offered
11.1.3 Pfizer Nasopharyngeal Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Nasopharyngeal Carcinoma Treatment Product Offered
11.2.3 Sanofi Nasopharyngeal Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Nasopharyngeal Carcinoma Treatment Product Offered
11.3.3 Merck Nasopharyngeal Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Merck Main Business Overview
11.3.5 Merck Latest Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly Nasopharyngeal Carcinoma Treatment Product Offered
11.4.3 Eli Lilly Nasopharyngeal Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Eli Lilly Main Business Overview
11.4.5 Eli Lilly Latest Developments
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Information
11.5.2 Teva Pharmaceutical Industries Nasopharyngeal Carcinoma Treatment Product Offered
11.5.3 Teva Pharmaceutical Industries Nasopharyngeal Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Teva Pharmaceutical Industries Main Business Overview
11.5.5 Teva Pharmaceutical Industries Latest Developments
11.6 Fresenius
11.6.1 Fresenius Company Information
11.6.2 Fresenius Nasopharyngeal Carcinoma Treatment Product Offered
11.6.3 Fresenius Nasopharyngeal Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Fresenius Main Business Overview
11.6.5 Fresenius Latest Developments
11.7 Cyclacel Pharmaceuticals
11.7.1 Cyclacel Pharmaceuticals Company Information
11.7.2 Cyclacel Pharmaceuticals Nasopharyngeal Carcinoma Treatment Product Offered
11.7.3 Cyclacel Pharmaceuticals Nasopharyngeal Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Cyclacel Pharmaceuticals Main Business Overview
11.7.5 Cyclacel Pharmaceuticals Latest Developments
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Information
11.8.2 F. Hoffmann-La Roche Nasopharyngeal Carcinoma Treatment Product Offered
11.8.3 F. Hoffmann-La Roche Nasopharyngeal Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 F. Hoffmann-La Roche Main Business Overview
11.8.5 F. Hoffmann-La Roche Latest Developments
11.9 CELGENE CORPORATION
11.9.1 CELGENE CORPORATION Company Information
11.9.2 CELGENE CORPORATION Nasopharyngeal Carcinoma Treatment Product Offered
11.9.3 CELGENE CORPORATION Nasopharyngeal Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 CELGENE CORPORATION Main Business Overview
11.9.5 CELGENE CORPORATION Latest Developments
11.10 BioDiem
11.10.1 BioDiem Company Information
11.10.2 BioDiem Nasopharyngeal Carcinoma Treatment Product Offered
11.10.3 BioDiem Nasopharyngeal Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 BioDiem Main Business Overview
11.10.5 BioDiem Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. Nasopharyngeal Carcinoma Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Ellence
Table 3. Major Players of Taxotere
Table 4. Major Players of Bleomycin
Table 5. Major Players of Methotrexate
Table 6. Nasopharyngeal Carcinoma Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Nasopharyngeal Carcinoma Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Nasopharyngeal Carcinoma Treatment Market Size Market Share by Type (2018-2023)
Table 9. Nasopharyngeal Carcinoma Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Nasopharyngeal Carcinoma Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Nasopharyngeal Carcinoma Treatment Market Size Market Share by Application (2018-2023)
Table 12. Global Nasopharyngeal Carcinoma Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Nasopharyngeal Carcinoma Treatment Revenue Market Share by Player (2018-2023)
Table 14. Nasopharyngeal Carcinoma Treatment Key Players Head office and Products Offered
Table 15. Nasopharyngeal Carcinoma Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Nasopharyngeal Carcinoma Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Nasopharyngeal Carcinoma Treatment Market Size Market Share by Regions (2018-2023)
Table 20. Global Nasopharyngeal Carcinoma Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Nasopharyngeal Carcinoma Treatment Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Nasopharyngeal Carcinoma Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Nasopharyngeal Carcinoma Treatment Market Size Market Share by Country (2018-2023)
Table 24. Americas Nasopharyngeal Carcinoma Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Nasopharyngeal Carcinoma Treatment Market Size Market Share by Type (2018-2023)
Table 26. Americas Nasopharyngeal Carcinoma Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Nasopharyngeal Carcinoma Treatment Market Size Market Share by Application (2018-2023)
Table 28. APAC Nasopharyngeal Carcinoma Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Nasopharyngeal Carcinoma Treatment Market Size Market Share by Region (2018-2023)
Table 30. APAC Nasopharyngeal Carcinoma Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Nasopharyngeal Carcinoma Treatment Market Size Market Share by Type (2018-2023)
Table 32. APAC Nasopharyngeal Carcinoma Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Nasopharyngeal Carcinoma Treatment Market Size Market Share by Application (2018-2023)
Table 34. Europe Nasopharyngeal Carcinoma Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Nasopharyngeal Carcinoma Treatment Market Size Market Share by Country (2018-2023)
Table 36. Europe Nasopharyngeal Carcinoma Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Nasopharyngeal Carcinoma Treatment Market Size Market Share by Type (2018-2023)
Table 38. Europe Nasopharyngeal Carcinoma Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Nasopharyngeal Carcinoma Treatment Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Nasopharyngeal Carcinoma Treatment
Table 47. Key Market Challenges & Risks of Nasopharyngeal Carcinoma Treatment
Table 48. Key Industry Trends of Nasopharyngeal Carcinoma Treatment
Table 49. Global Nasopharyngeal Carcinoma Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Nasopharyngeal Carcinoma Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Nasopharyngeal Carcinoma Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Nasopharyngeal Carcinoma Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Pfizer Details, Company Type, Nasopharyngeal Carcinoma Treatment Area Served and Its Competitors
Table 54. Pfizer Nasopharyngeal Carcinoma Treatment Product Offered
Table 55. Pfizer Nasopharyngeal Carcinoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. Sanofi Details, Company Type, Nasopharyngeal Carcinoma Treatment Area Served and Its Competitors
Table 59. Sanofi Nasopharyngeal Carcinoma Treatment Product Offered
Table 60. Sanofi Main Business
Table 61. Sanofi Nasopharyngeal Carcinoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Sanofi Latest Developments
Table 63. Merck Details, Company Type, Nasopharyngeal Carcinoma Treatment Area Served and Its Competitors
Table 64. Merck Nasopharyngeal Carcinoma Treatment Product Offered
Table 65. Merck Main Business
Table 66. Merck Nasopharyngeal Carcinoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Merck Latest Developments
Table 68. Eli Lilly Details, Company Type, Nasopharyngeal Carcinoma Treatment Area Served and Its Competitors
Table 69. Eli Lilly Nasopharyngeal Carcinoma Treatment Product Offered
Table 70. Eli Lilly Main Business
Table 71. Eli Lilly Nasopharyngeal Carcinoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Eli Lilly Latest Developments
Table 73. Teva Pharmaceutical Industries Details, Company Type, Nasopharyngeal Carcinoma Treatment Area Served and Its Competitors
Table 74. Teva Pharmaceutical Industries Nasopharyngeal Carcinoma Treatment Product Offered
Table 75. Teva Pharmaceutical Industries Main Business
Table 76. Teva Pharmaceutical Industries Nasopharyngeal Carcinoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Teva Pharmaceutical Industries Latest Developments
Table 78. Fresenius Details, Company Type, Nasopharyngeal Carcinoma Treatment Area Served and Its Competitors
Table 79. Fresenius Nasopharyngeal Carcinoma Treatment Product Offered
Table 80. Fresenius Main Business
Table 81. Fresenius Nasopharyngeal Carcinoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Fresenius Latest Developments
Table 83. Cyclacel Pharmaceuticals Details, Company Type, Nasopharyngeal Carcinoma Treatment Area Served and Its Competitors
Table 84. Cyclacel Pharmaceuticals Nasopharyngeal Carcinoma Treatment Product Offered
Table 85. Cyclacel Pharmaceuticals Main Business
Table 86. Cyclacel Pharmaceuticals Nasopharyngeal Carcinoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Cyclacel Pharmaceuticals Latest Developments
Table 88. F. Hoffmann-La Roche Details, Company Type, Nasopharyngeal Carcinoma Treatment Area Served and Its Competitors
Table 89. F. Hoffmann-La Roche Nasopharyngeal Carcinoma Treatment Product Offered
Table 90. F. Hoffmann-La Roche Main Business
Table 91. F. Hoffmann-La Roche Nasopharyngeal Carcinoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. F. Hoffmann-La Roche Latest Developments
Table 93. CELGENE CORPORATION Details, Company Type, Nasopharyngeal Carcinoma Treatment Area Served and Its Competitors
Table 94. CELGENE CORPORATION Nasopharyngeal Carcinoma Treatment Product Offered
Table 95. CELGENE CORPORATION Main Business
Table 96. CELGENE CORPORATION Nasopharyngeal Carcinoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. CELGENE CORPORATION Latest Developments
Table 98. BioDiem Details, Company Type, Nasopharyngeal Carcinoma Treatment Area Served and Its Competitors
Table 99. BioDiem Nasopharyngeal Carcinoma Treatment Product Offered
Table 100. BioDiem Main Business
Table 101. BioDiem Nasopharyngeal Carcinoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. BioDiem Latest Developments
List of Figures
Figure 1. Nasopharyngeal Carcinoma Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nasopharyngeal Carcinoma Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Nasopharyngeal Carcinoma Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Nasopharyngeal Carcinoma Treatment Sales Market Share by Country/Region (2022)
Figure 8. Nasopharyngeal Carcinoma Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Nasopharyngeal Carcinoma Treatment Market Size Market Share by Type in 2022
Figure 10. Nasopharyngeal Carcinoma Treatment in Hospital Pharmacies
Figure 11. Global Nasopharyngeal Carcinoma Treatment Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Nasopharyngeal Carcinoma Treatment in Retail Pharmacies
Figure 13. Global Nasopharyngeal Carcinoma Treatment Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Nasopharyngeal Carcinoma Treatment in Online Pharmacies
Figure 15. Global Nasopharyngeal Carcinoma Treatment Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Nasopharyngeal Carcinoma Treatment Market Size Market Share by Application in 2022
Figure 17. Global Nasopharyngeal Carcinoma Treatment Revenue Market Share by Player in 2022
Figure 18. Global Nasopharyngeal Carcinoma Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Nasopharyngeal Carcinoma Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Nasopharyngeal Carcinoma Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Nasopharyngeal Carcinoma Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Nasopharyngeal Carcinoma Treatment Value Market Share by Country in 2022
Figure 24. United States Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Nasopharyngeal Carcinoma Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Nasopharyngeal Carcinoma Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Nasopharyngeal Carcinoma Treatment Market Size Market Share by Application in 2022
Figure 31. China Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Nasopharyngeal Carcinoma Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Nasopharyngeal Carcinoma Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Nasopharyngeal Carcinoma Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Nasopharyngeal Carcinoma Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Nasopharyngeal Carcinoma Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Nasopharyngeal Carcinoma Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Nasopharyngeal Carcinoma Treatment Market Size Market Share Forecast by Application (2024-2029)